Results 71 to 80 of about 6,003,133 (188)

A 51‐year‐old female presenting with headache and vision loss

Headache: The Journal of Head and Face Pain, Volume 66, Issue 8, Page 1928-1932, September 2026.
Laurel Ovrom, Zachary Pardieck, Randy Christopher Bowen, Neena R. Cherayil   +3 more
wiley   +1 more source

Characterization of retinal pigment epithelium layer in healthy and diseased retinas with high‐resolution adaptive optics transscleral flood illumination imaging

Acta Ophthalmologica, Volume 104, Issue 3, Page e277-e291, May 2026.
Abstract Purpose The retinal pigment epithelium (RPE) is critical in the pathophysiology of retinal diseases, such as age‐related macular degeneration. Adaptive optics transscleral flood illumination (AO‐TFI) offers rapid, detailed morphometric characterization of the RPE layer.
Leila Sara Eppenberger, Safa Mohanna, Sohrab Ferdowsi, Sonja Simon‐Zoula, Oliver Pfäffli, Christoph Amstutz, Lucas M. Bachmann, Michael A. Thiel, Martin K. Schmid   +8 more
wiley   +1 more source

Pretreatment characteristics of patients with central serous chorioretinopathy.

, 2023
Pretreatment characteristics of patients with central serous chorioretinopathy.
Taiji Sakamoto (104961), Hiroto Terasaki (104937), Hideki Shiihara (10803160), Juun Horie (14659713), Shozo Sonoda (104941), Naohisa Mihara (14659710), Ryoh Funatsu (10803163)   +6 more
core   +1 more source

Phase II Trial of Opaganib Addition in Metastatic Castration‐Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide

Cancer Medicine, Volume 15, Issue 4, April 2026.
This phase II trial investigated the safety and efficacy of opaganib in combination with abiraterone or enzalutamide in patients with castration‐resistant prostate cancer (CRPC). While the study did not meet its disease control efficacy endpoint, there was evidence of clinical activity in a subset of patients.
Jacqueline T. Brown, Bassel Nazha, Anna C. Ferreira, Kent Armeson, Elizabeth G. Hill, Besim Ogretmen, Shikhar Mehrotra, Alan Brisendine, George Magrath, Terry F. Plasse, Theodore Stewart Gourdin, Omer Kucuk, Michael Lilly   +12 more
wiley   +1 more source

In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy

, 2015
Nooshin Bazzazi,1 Mohammad Ahmadpanah,2 Siamak Akbarzadeh,1 Mohammad Ali Seif Rabiei,3 Edith Holsboer-Trachsler,4 Serge Brand4,5 1Department of Ophthalmology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran; 2Research Center ...
Ahmadpanah M, Br, Bazzazi N, S, Akbarzadeh S, Seif Rabiei MA, Holsboer-Trachsler E   +6 more
core  

A case of macular damage following micropulse laser treatment for central serous chorioretinopathy

Journal of International Medical Research
Subthreshold micropulse laser treatment has proven to be an effective treatment for central serous chorioretinopathy. We report a rare case of localized macular damage following 577-nm subthreshold micropulse laser therapy in a patient with central ...
Jianli Wei, Lishuang Chen
doaj   +1 more source

Persistent subretinal fluid due to central serous chorioretinopathy after retinal detachment surgery

, 2011
María Moreno-López, Marta Pérez-López, Pilar Casas-Llera, Elena Jarrín, Francisco José Muñoz-NegreteOphthalmology Unit, Hospital Ramón y Cajal, Madrid ...
Pérez-López M, Jarrín E, Muñoz-Negrete FJ, Casas-Llera P, Moreno-López M   +4 more
core  

Resolution of subretinal fluid in intractable central serous chorioretinopathy with high-dose intravitreal aflibercept

American Journal of Ophthalmology Case Reports
Purpose: To report an unusual case of a patient with intractable central serous chorioretinopathy with a dramatic treatment response to high-dose intravitreal aflibercept. Methods: Retrospective case report.
Jonathan B. Lin, Loh-Shan B. Leung
doaj   +1 more source

Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy

BMC Ophthalmology, 2019
Purpose Central serous chorioretinopathy (CSCR) is a complex ocular entity that, in its chronic form, can lead to serious visual impairment and morphological damage to the retina.
Maciej Gawęcki, Agnieszka Jaszczuk-Maciejewska, Anna Jurska-Jaśko, Małgorzata Kneba, Andrzej Grzybowski   +4 more
doaj   +1 more source

Characteristics of patients with central serous chorioretinopathy by treatment outcome.

, 2023
Characteristics of patients with central serous chorioretinopathy by treatment outcome.
Taiji Sakamoto (104961), Hiroto Terasaki (104937), Hideki Shiihara (10803160), Juun Horie (14659713), Shozo Sonoda (104941), Naohisa Mihara (14659710), Ryoh Funatsu (10803163)   +6 more
core   +1 more source